Fluidomica
- Company typePrivate
- Founded-
- Headquarters—
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
Fluidomica firmographics
Firmographics- Name
- Fluidomica
- Legal name
- Fluidomica
- Website
- https://fluidomica.com
- Company type
- Private
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Fluidomica industry classification
Industry- Product category
- Radiopharmaceutical Manufacturing Consumables
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Chemical Manufacturing (325), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Radioisotope Production (Reactor/Cyclotron/Gamma) (HLAIAGAD)
- akta.pro secondary industries
- Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC) (EUAKAIAC), Radiopharmaceutical CDMO & Manufacturing (GMP Fill-Finish) (HLAIAGAF), Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain) (EUAKAIAE)
Keywords
Fluidomica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D
Distribution channels1 record
Fluidomica product offering
Product offeringCore offering
Fluidomica develops, produces, and commercializes disposable cassettes used in the production of radioisotopes and radiopharmaceuticals, as well as cyclotron liquid target solutions used in the production of radiometals. Both product lines are designed for automated, cyclotron-based radiopharmaceutical manufacturing and are sold to radiopharma manufacturers and medical facilities. The company now operates as an integrated subsidiary of IBA (Ion Beam Applications S.A.) and reaches customers through IBA's global radiopharmaceutical solutions platform.
Product overview
Fluidomica is a specialized technology company focused on the development, production, and commercialization of two core product lines: disposable cassettes for radioisotope and radiopharmaceutical production, and cyclotron liquid target solutions for radiometals' production. The company operates as an integrated business unit within IBA (Ion Beam Applications S.A.), leveraging IBA's global infrastructure as the world leader in particle accelerator technology.
Differentiator
Problem solved
Functional benefit
Products and services
- Disposable Cassettes for Radioisotopes and Radiopharmaceuticals Production
Companies that use Fluidomica
Customer profileSegments1 record
Ideal customer profiles1 record
Fluidomica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Fluidomica partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IBA (Ion Beam Applications S.A.)coreFluidomica has been acquired and integrated into IBA as a subsidiary. IBA is the world leader in particle accelerator technology and a leading supplier of proton therapy equipment. IBA is also a leading player in industrial sterilization, radiopharmaceuticals, and dosimetry. Fluidomica now operates as an integrated IBA company focused on disposable cassettes and liquid target solutions for radiopharmaceutical production.
Recent moves5 records
Expansion highlights3 records
Fluidomica competitors and assessment
Company assessmentDirect peers
- Trasis: Belgian company developing synthesis modules and single-use cassettes for radiopharmaceutical production, directly overlapping with Fluidomica's cassette and target solution offering.
- Tema Sinergie: Italian manufacturer of automated synthesis modules and disposable single-use cassettes for radiopharmaceutical production; competes head-to-head with Fluidomica's cassettes for cyclotron-based radioisotope workflows.
- ABX Advanced Biochemical Compounds: German supplier of precursors, cassettes, and consumables for radiopharmaceutical synthesis; closely comparable as a cassette/precursor provider to radiopharma manufacturers.
- NorthStar Medical Radioisotopes: US radioisotope production company focused on Mo-99 and other medical isotopes using novel production approaches; comparable as a cyclotron/reactor-based radioisotope manufacturer that depends on similar target and chemistry consumables.
Broad incumbents
- GE Healthcare (Radiopharma): Major incumbent in medical imaging and radiopharma supplies (e.g., PET tracers, contrast agents); overlaps with Fluidomica's customer base and competes broadly in radiopharmaceutical infrastructure and consumables.
- Curium Pharma: Global radiopharmaceutical manufacturer and distributor of diagnostic and therapeutic nuclear medicines; a potential customer-side comparable to Fluidomica in the radiopharmaceutical manufacturing ecosystem.
- IBA Radiopharma Solutions (parent): IBA's broader radiopharma solutions division supplies cyclotrons, automation, target systems, and chemistry consumables; owns Fluidomica and offers a much wider portfolio that overlaps with Fluidomica's products as part of its end-to-end offering.
- Eckert & Ziegler Strahlen- und Medizintechnik: German-based radiopharmaceutical services and isotope production company; competes broadly with Fluidomica/IBA in supplying radioisotopes and radiopharma manufacturing infrastructure, including target-related technology.
- PETNET Solutions (Siemens Healthineers):
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Fluidomica social profiles
Digital presenceFluidomica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Fluidomica leadership team
Management profileNumber of profiles
Fluidomica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Fluidomica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Fluidomica
What does Fluidomica do?
Fluidomica develops, produces, and commercializes disposable cassettes used in the production of radioisotopes and radiopharmaceuticals, as well as cyclotron liquid target solutions used in the production of radiometals. Both product lines are designed for automated, cyclotron-based radiopharmaceutical manufacturing and are sold to radiopharma manufacturers and medical facilities. The company now operates as an integrated subsidiary of IBA (Ion Beam Applications S.A.) and reaches customers through IBA's global radiopharmaceutical solutions platform.
Is Fluidomica a public or private company?
Fluidomica is a private company. It is classified as corporate owned and is currently acquired.
When was Fluidomica founded?
Fluidomica was founded in -1. It employs 1 to 10 people.
Who are Fluidomica's main competitors?
Direct peers on record are Trasis, Tema Sinergie, ABX Advanced Biochemical Compounds and NorthStar Medical Radioisotopes. Broad incumbents are GE Healthcare (Radiopharma), Curium Pharma, IBA Radiopharma Solutions (parent), Eckert & Ziegler Strahlen- und Medizintechnik and PETNET Solutions (Siemens Healthineers).
Does Fluidomica have an API?
No public API is recorded for Fluidomica.
What industry is Fluidomica in?
Fluidomica's product category is Radiopharmaceutical Manufacturing Consumables. Its primary akta.pro industry code is HLAIAGAD, Radioisotope Production (Reactor/Cyclotron/Gamma), with a secondary code of EUAKAIAC, Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC). Its NAICS code is 339112 and its SIC code is 3841.